EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Advancing Biopharmaceutical Innovation Through Cell Encapsulation and Biomimetic Therapeutic Systems
My interest in biopharmaceutical engineering began during my senior year as an undergraduate For my capstone project I worked on the encapsulation of...
Advisory Board
KNOWLEDGE BANK
-
Articles
Mass Spectrometers: Principles, Instrumentation, Applications, and Future Perspectives
Mass spectrometry MS is one of the most powerful analytical technologies available in modern science It enables the identification characterization and quantification of compounds based on their masstocharge ratio mz Since its development in the early twentieth century mass spectrometry has evolved from a basic analytical tool into a sophisticated technology capable of studying highly complex biol...
-
Techno Trends
FDA Authorises Aletta for Autonomous Blood Collection
The US Food and Drug Administration FDA has authorised Aletta the first standalone robotic device designed to collect blood from a patients arm without handson operator intervention
-
Projects
Cambrex Expands Milan R&D Operations With US$30 Million Investment
Cambrex has begun construction of a new research and development facility at its Profarmico Milano site in Italy supported by a US million investment The initiative is designed
-
Research Insights
CAVE-Onc: Graph-constrained agentic validation for cross-domain contradictions in CDISC oncology submissions
The CDISC Rules Engine CORE provides industrystandard validation for Study Data Tabulation Model SDTM submissions yet its imperative domainscoped architecture cannot express crossdomain contradictions
-
White Papers
Accelerating In-Vitro Antibody Discovery with Artificial Intelligence
Antibodies have transformed modern medicine reshaping treatment paradigms across autoimmune disorders oncology and infectious diseases As one of the most versatile and successful therapeutic modalities
TOP ARTICLES
-
1
Decentralization - The Future of Clinical Trials
Nikhila Shashikanth
Decentralized clinical trials (DCTs) leads with a premise to leverage technology to transform the traditional clinical trials model. Incorporating digital tools, telemedicine, and real-world data, DCT...
-
2
Future of Pharma IT Infrastructure: Building Agile, Secure, and Data-Driven Enterprises
Lakshmi
American pharmaceutical companies are discovering that IT infrastructure sets the ceiling on everything else: how fast a product scales, how quickly quality issues surface, how far AI can be trusted....
-
3
Innovative Therapies: How Cell and Gene Technologies are Changing Lives
Kate Williamson
Medical science stands transformed through pioneering advancements in cell and gene therapy which treat chronic diseases and genetic conditions at their foundations. Through genome-editing technologie...
-
4
Why Great Science Still Fails at the Regulatory Finish Line
Lakshmi
Pharmaceutical organizations are built to prove a molecule works. Regulators, at the decision point, ask something else: can it be reliably made, have the sites been verified, does the trial design su...
-
5
Modern Mental Health Medications: A Guide to Antidepressants, Anxiety Drugs, and New Treatments
No Author
Mental health is no longer a hidden issue—it's a vital focus in healthcare worldwide. With millions seeking effective treatment options, the landscape of mental health medications has expand...
press releasesRead more...
Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab) in the US FacebookPinterest
Invagen Pharmaceuticals Inc a wholly owned subsidiary of Cipla Limited BSE NSE CIPLA today announced that it has entered into a strategic partnership with Qilu Pharmaceutical Co Ltd
Fresenius Kabi Launches Generic Sugammadex in Simplist® Ready‑to‑Administer Prefilled Syringe in the U.S.
Fresenius Kabi a global healthcare company part of the Fresenius Group specializing in lifesaving therapies and technologies today announced the US launch of the FDAapproved generic Sugammadex
Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Continued Collaboration with the University of Georgia
Lkahi Therapeutics a subsidiary of Glucotrack Inc Nasdaq GCTK today announced the continued participation of the University of Georgias Student Industry Fellows Program in the ai Futures Lab
Scholar Rock Receives FDA Fast Track Designation for Apitegromab Facioscapulohumeral Muscular Dystrophy (FSHD) Program as Participant Dosing Commences in Phase 2 FORGE Trial
Scholar Rock NASDAQ SRRK a global biopharmaceutical company dedicated to improving the lives of patients with rare severe and debilitating neuromuscular diseases by applying its worldleading platform
Events Read more...
03 - 05
Sep 20265th MENA Congress for Rare Diseases 2026
Beach Rotana Hotel, Abu Dhabi,...
09 - 10
Sep 2026iPSC Drug Development Summit
Hyatt Regency Boston Harbour,...
14 - 16
Sep 202614 - 15
Sep 202616th American DDF Summit
Omni Boston Hotel at the Seapo...
15 - 17
Sep 2026COPD Drug Development Summit 2026
Street, Boston, MA 02210, USA
21 - 23
Sep 2026Cell & Gene Therapy World Conference
Miami, Florida, USA
21 - 23
Sep 2026Cancer R&D World Conference
Hilton Garden Inn Miami Dolphi...
22 - 23
Sep 2026PDA Advanced Parenteral Therapeutics & Quality
Illume Hotel Taipei, Taiwan
LATEST NEWSRead more...
FDA Approves First Drug to Treat Alexander Disease
The US Food and Drug Administration FDA has approved Zanvastro zilganersen injection for the treatment of Alexander disease in paediatric and adult patients It is the first FDAapproved treatment
AbbVie Completes Acquisition of Apogee Therapeutics
AbbVie has completed its acquisition of Apogee Therapeutics bringing the biotechnology company and its pipeline of antibodybased treatments into AbbVie
EpiVax Launches AI-Enhanced Models for Immunogenicity Prediction
EpiVax Inc has launched AIenhanced features for ISPRI its in silico platform for assessing the immunogenicity risk of biotherapeutics The update includes an improved JanusMatrix model
Thermo Fisher Scientific Launches Multiskan™ Ease Absorbance Microplate Reader
Thermo Fisher Scientific has launched the Thermo Scientific Multiskan Ease Absorbance Microplate Reader designed to simplify routine laboratory analysis involving proteins cells and microorganisms
Juniper Biosciences Receives FDA Breakthrough Therapy Designation for JBS-003
Juniper Biosciences has received Breakthrough Therapy Designation from the US Food and Drug Administration FDA for JBS Ffluoromisonidazole or FMISO a hypoxia tracer being developed to guide reduced radiation therapy in patients with HPVpositive oropharyngeal carcinoma OPC
FDA approves PharmaEssentia’s BESREMi for adults with essential thrombocythaemia
PharmaEssentia USA Corporation a subsidiary of PharmaEssentia Corporation has received approval from the US Food and Drug Administration FDA for BESREMi ropeginterferon alfabnjft to treat adults with essential thrombocythaemia ET a rare form of blood cancer

